Home / Science & tech / Anti Microbial Resistance

Anti Microbial Resistance

Why in News

The launch of Nafithromycin (Miqnaf)—India’s first indigenously developed antibiotic in over 30 years—marks a critical step in the battle against Antimicrobial Resistance (AMR). However, experts warn that the AMR crisis is too vast for one solution and demands sustained, multi-pronged action.


What is Antimicrobial Resistance (AMR)?

AspectDetails
DefinitionAMR occurs when microorganisms resist drugs (like antibiotics, antivirals), making infections harder to treat.
Nickname“Superbugs”
Global Threat StatusListed among WHO’s top 10 global health threats
Health Impact (2019)India: 2.97 lakh deaths; Globally: 1.27 million deaths (IHME Report)
Future ProjectionsBy 2050: 1.91 million direct deaths; 8.22 million associated deaths (The Lancet)

Key Issues Leading to AMR in India

FactorDescription
Overuse of AntibioticsPrescribed even for viral infections; 59% from WHO “Watch” group in 2022
Weak Healthcare InfraLack of diagnostics leads to broad-spectrum use; poor hygiene fuels spread
No New AntibioticsPharma prefers chronic disease drugs; no new Indian antibiotic for 30 years until 2024
Unregulated Animal Use70% used in livestock and aquaculture; enters food chain and water
Environmental PollutionPharma waste, untreated sewage contaminate rivers, creating resistance hotspots

Consequences of Rising AMR

ConsequenceImpact
HealthUntreatable infections (e.g., TB); surgeries and chemotherapy become riskier
Economic Cost$1 trillion healthcare cost by 2050; up to $3.4 trillion GDP loss by 2030
Food SecurityResistant bacteria in poultry; fungal-resistant crop diseases (e.g., blight in wheat)
Environmental SpreadAMR genes spread via sewage, rivers (e.g., Ganga), migratory birds
Social ImpactPoor communities more vulnerable; public trust in treatment declines

Measures Underway to Tackle AMR in India

Measure CategoryInitiatives
Policy FrameworkNational Action Plan on AMR (2017); NCDC coordinates across 27 states
SurveillanceNARS-Net monitors 9 pathogens including E. coli
Drug Regulation156 FDCs banned (Aug 2024); Schedule H1 restricts OTC sales of last-resort antibiotics
State-Level ActionKerala banned OTC antibiotics (Jan 2024), a first in India
R&D SupportC-CAMP AMR Challenge; startups like Bugworks; pharma companies like Wockhardt active
Awareness CampaignsRed Line Campaign discourages use of antibiotics without prescription
International Tie-upsIndia part of WHO’s GLASS for global AMR data tracking

Further Measures to Combat AMR

Suggested MeasureDescription
Strengthen RegulationEnforce Schedule H1; regulate pharma discharge; ban non-therapeutic livestock antibiotics
Incentivize R&DGrants, tax breaks for antibiotics; expand support for AMR-focused startups
Expand StewardshipMandatory AMSPs; train doctors; use AI for real-time AMR tracking
Diagnostic InfrastructureAffordable, rapid tests; rural diagnostics to reduce empirical prescribing
Public AwarenessTrain ASHA workers; educate farmers on safe livestock practices
One Health ApproachIntegrate health, agriculture, veterinary, environment sectors for unified AMR management

Prelims MCQs

1. With reference to Antimicrobial Resistance (AMR), consider the following statements:

  1. AMR occurs when bacteria and viruses become more susceptible to antibiotics and antivirals.
  2. The World Health Organization lists AMR as one of the top 10 global health threats.
  3. AMR-related deaths are projected to exceed 8 million annually by 2050 if unchecked.

Which of the above statements are correct?
A. 1 and 2 only
B. 2 and 3 only
C. 1 and 3 only
D. 1, 2 and 3

Answer: B. 2 and 3 only


2. Consider the following regarding the WHO’s “Watch” group of antibiotics:

  1. They are meant for routine use in mild infections.
  2. In India, a large proportion of consumed antibiotics fall under this group.
  3. Their overuse contributes significantly to antimicrobial resistance.

Which of the statements given above is/are correct?
A. 1 only
B. 2 and 3 only
C. 1 and 2 only
D. 1, 2 and 3

Answer: B. 2 and 3 only


3. Which of the following are initiatives taken by India to tackle AMR?

  1. Red Line Campaign
  2. NARS-Net
  3. GLASS Surveillance System
  4. National Action Plan on AMR (2017)

Select the correct answer using the code below:
A. 1 and 2 only
B. 2, 3 and 4 only
C. 1, 2 and 4 only
D. 1, 2, 3 and 4

Answer: D. 1, 2, 3 and 4


Mains Question

GS Paper 3 – Science and Technology / Health

“The recent launch of Nafithromycin is a welcome step, but the AMR challenge in India requires more than just new drugs.”
Discuss the multifactorial causes of AMR in India and suggest a sustainable roadmap incorporating the One Health approach.

Read more newsletters